Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-002703
Filing Date
2025-03-11
Accepted
2025-03-11 16:01:30
Documents
96
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vygr-20241231x10k.htm   iXBRL 10-K 3618612
2 EX-19.1 vygr-20241231xex19d1.htm EX-19.1 95303
3 EX-21.1 vygr-20241231xex21d1.htm EX-21.1 4857
4 EX-23.1 vygr-20241231xex23d1.htm EX-23.1 7249
5 EX-31.1 vygr-20241231xex31d1.htm EX-31.1 10282
6 EX-31.2 vygr-20241231xex31d2.htm EX-31.2 10229
7 EX-32.1 vygr-20241231xex32d1.htm EX-32.1 12987
8 GRAPHIC vygr-20241231x10k006.jpg GRAPHIC 80932
9 GRAPHIC vygr-20241231x10k008.jpg GRAPHIC 1248
  Complete submission text file 0001558370-25-002703.txt   13722132

Data Files

Seq Description Document Type Size
10 EX-101.SCH vygr-20241231.xsd EX-101.SCH 78255
11 EX-101.CAL vygr-20241231_cal.xml EX-101.CAL 79643
12 EX-101.DEF vygr-20241231_def.xml EX-101.DEF 349686
13 EX-101.LAB vygr-20241231_lab.xml EX-101.LAB 640393
14 EX-101.PRE vygr-20241231_pre.xml EX-101.PRE 559540
99 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20241231x10k_htm.xml XML 2448342
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37625 | Film No.: 25727490
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)